Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease

Journal of Rheumatology

Volumn 24, Issue 8, 1997, Pages 1504-1509

  Jongen Lavrencic, Mojca ^a,e   Peeters, H Ralph M ^a   Wognum, Albertus ^b   Vreugdenhil, Gerard ^c   Breedveld, Ferdinand C ^d   Swaak, Anton J G ^a,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ST JOSEPH HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CENTRAL LABORATORY   (Netherlands)

Author keywords

anemia; chronic disease; cytokines; erythropoietin receptor; tumor necrosis factor

Indexed keywords

ERYTHROPOIETIN RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTHRITIS, RHEUMATOID; BONE MARROW; CELLS, CULTURED; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROBLASTS; ERYTHROPOIETIN; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, TRANSFERRIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030808921     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Means RT Jr, Krantz SB: Progress in understanding the pathogenesis of the anemia of chronic disease (review). Blood 1992;80:1639-47.
2. Means RT Jr, Dessypris EN, Krantz SB: Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol 1992;150:59-64.
3. Means RT Jr, Krantz SB: Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest 1993;91:416-9.
4. Fuchs J, Hausen A, Reibnegger G, et al: Immune activation and the anemia associated with chronic inflammatory disorders. Eur J Haematol 1991;46:65-70.
5. Vreugdenhil G, Lowenberg B, Van Eijk HG, Swaak AJ: Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur J Clin Invest 1992;22:488-93.
6. Vreugdenhil G, Koos MJ, Van Eijk HG, Swaak AJG: Impaired iron uptake and transferrin binding by erythroblast in the anemia of rheumatoid arthritis. Br J Rheumatol 1990;29:335-9.
7. Denz H, Fuchs D, Huber H, et al: Correlation between neopterin, interferon-gamma and haemoglobin in patients with hematological disorders. Eur J Haematol 1990;44:186-9.
8. Jelkman W, Pagel H, Wolff M, Fandrey J: Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 1992;50:301-8.
9. Baer AN, Dessypris EN, Goldwasser E, Krantz SB: Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol 1987;66:559-64.
10. Swaak AJG, Van Rooyen A, Nieuwenhuis E, Aarden LA: Interleukin-6 in synovial fluid and serum of patients with rheumatic diseases. Scand J Rheumatol 1988;17:469-74.
11. Barrera P, Boerbooms AMT, Janssen EM, et al: Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α, and interleukin-6 levels in rheumatoid arthritis. Arthritis Rheum 1993;36:1070-9.
12. Teppo AM, Maury CPJ: Radioimmunoassay of tumor necrosis factor in serum. Clin Chem 1987;33:2024-7.
13. Dasgupta B, Corhill M, Kirkham B, Gibson T, Panayi G: Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis. J Rheumatol 1992;19:22-5.
14. Tanabe M, Ochi T, Tomita T, et al: Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow of patients with rheumatoid arthritis. J Rheumatol 1994;21:830-5.
15. Wendung D, Racadot E, Wijdenes J: Treatment of severe rheumatoid arthritis by anti-interleukin-6 monoclonal antibodies. J Rheumatol 1993;20:259-62.
16. Elliott MJ, Maini RN, Feldman M, et al: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
17. Vreugdenhil G, Lowenberg B, Van Eijk HG, Swaak AJ: Anaemia of chronic disease in rheumatoid arthritis. Raised serum interleukin-6 (IL-6) levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis. Rheumatol Int 1990;10:127-30.
18. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
19. Ritchie DM, Boyle JA, McInnes JM, et al: Clinical studies with an articular index for the assessments of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;27:393-406.
20. Helle M, Boeije L, De Groot ER, De Vos A, Aarden LA: Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: Synovial fluids and sera. J Immunol Methods 1991;138:42-56.
21. van Kooten C, Rensink I, Pascual-Salcebo D, van Oers R, Aarden LA: Monokine production by human T-cells: IL-1α production restricted to memory T-cells. J Immunol 1991;146:2654-8.
22. Bot FJ, van Eijk L, Breeders L, Aarden LA, Lowenberg B: Interleukin-6 synergizes with M-CSF in the formation of macrophage colonies from purified human marrow progenitor cells. Blood 1988;71:1609-14.
23. Wognum AW, Krystal G, Eaves CJ, Eaves AC, Lansdorp PM: Increased erythropoietin-receptor expression on CD34-positive bone marrow cells from patients with chronic myeloid leukemia. Blood 1992;79:642-9.
24. Wognum AW, Lansdorp PM, Humphries K, Krystal G: Detection and isolation of the erythropoietin receptor using biotinylated erythropoietin. Blood 1990;76:697-705.
25. Terstappen LWMM, Shah VO, Conrad MP, Recktenwald D, Loken MR: Discriminating between damaged and intact cells in fixed flow cytometric samples. Cytometry 1988;9:477-84.
26. Vreugdenhil G, Jongen M, Swaak AJG: Lack of correlation of serum cytokine levels with bone marrow cytokine production and effects on erythropoiesis. Nephron 1994;67:492-3.
27. Asano S, Okano A, Ozawa K, et al: In vivo effects of recombinant human interleukin-6 in primates: Stimulated production of platelets. Blood 1990;75:1602-5.
28. Nieken J, Mulder NH, Buter J, et al: Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients. Blood 1995;86:900-5.
29. Hirayama M, Kohgo Y, Kondo H, et al: Regulation of iron metabolism in HepG2 cells: A possible role for cytokines in the hepatic deposition of iron. Hepatology 1993;18:874-80.
30. Wegenka UM, Buschmann J, Lutticken C, Heinrich PC, Horn F: Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. MCB 1993;13:276-88.
31. Kobune M, Kohgo Y, Kato J, Miyazaki E, Niitsu Y: Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats. Hepatology 1994;19:1468-75.
32. Johnson CS, Cook CA, Furmanski P: In vivo suppression of erythropoiesis by tumor necrosis factor-alpha: Reversal with exogenous erythropoietin. Exp Hematol 1990;18:109-13.
33. Jelkmann WE, Fandrey J, Frede S, Pagel H: Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states. Ann NY Acad Sci 1994;718:300-9.
34. Vreugdenhil G, Wognum AW, Van Eijk HG, Swaak AJ: Anaemia in rheumatoid arthritis: The role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness. Ann Rheum Dis 1990;49:93-8.